| Code | CSB-RA33255A1GMY |
| Size | US$210 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
| Application | Recommended Dilution |
|---|---|
| ELISA | 1:10000-1:50000 |
| WB | 1:500-1:5000 |
| GICA | 1:1000-1:10000 |
The SARS-CoV-2 nucleocapsid protein plays a central role in viral replication and assembly, making it one of the most abundant and immunogenic proteins produced during infection. Its high expression levels and structural conservation have established it as a primary target for diagnostic development and fundamental coronavirus research, enabling detection of viral presence and investigation of host-pathogen interactions.
This recombinant monoclonal antibody targeting the SARS-CoV-2 nucleocapsid protein offers the consistency and reliability that demanding research applications require. As a sequence-defined reagent produced through recombinant technology, it eliminates the lot-to-lot variability inherent in traditional hybridoma-derived antibodies, ensuring your experimental results remain reproducible across studies. The mouse scFv fusion with human IgG1 Fc format provides stable performance while maintaining compatibility with standard secondary detection systems.
Validation data demonstrates exceptional specificity for SARS-CoV-2 nucleocapsid protein without cross-reactivity against related coronavirus proteins including NL63-CoV, HCoV-OC43, HCoV-229E, and HCoV-HKU1, a critical consideration when distinguishing SARS-CoV-2 from endemic human coronaviruses. In Western blot analysis using His-tagged recombinant nucleocapsid protein expressed in E. coli, the antibody detects a band at approximately 55 kDa, slightly higher than the predicted 48 kDa molecular weight, likely reflecting post-translational modifications or anomalous migration patterns common with highly basic proteins like nucleocapsid. Functional ELISA testing reveals strong binding activity with an EC50 of 1.586 ng/ml, while colloidal gold immunochromatography assay validation demonstrates clean background signal with detection sensitivity reaching 125 ng/ml.
This antibody supports researchers developing SARS-CoV-2 diagnostic platforms, studying viral protein biology, or requiring a dependable nucleocapsid detection reagent across ELISA, Western blot, and lateral flow applications.
There are currently no reviews for this product.